Deciphera Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 38.3 million compared to USD 32.49 million a year ago. Net loss was USD 48.56 million compared to USD 43.06 million a year ago. Basic loss per share from continuing operations was USD 0.57 compared to USD 0.6 a year ago. Diluted loss per share from continuing operations was USD 0.57 compared to USD 0.6 a year ago.
For the six months, revenue was USD 71.75 million compared to USD 61.72 million a year ago. Net loss was USD 98.17 million compared to USD 89.95 million a year ago. Basic loss per share from continuing operations was USD 1.17 compared to USD 1.31 a year ago. Diluted loss per share from continuing operations was USD 1.17 compared to USD 1.31 a year ago.